Passa al contenuto
Merck

Association between low education and higher global cardiovascular risk.

Journal of clinical hypertension (Greenwich, Conn.) (2015-02-24)
Tiziana Di Chiara, Alessandra Scaglione, Salvatore Corrao, Christiano Argano, Antonio Pinto, Rosario Scaglione
ABSTRACT

This study was designed to evaluate the impact of educational status on global cardiovascular risk in a southern Italian urban population. The study population consisted of 488 consecutive outpatients aged 18 years and older. Educational status was categorized according to the number of years of formal education as follows: (1) low education group (<10 years) and (2) medium-high education group (10-15 years). In both groups, cardiometabolic comorbidities (obesity, visceral obesity, diabetes, dyslipidemia, metabolic syndrome, microalbuminuria, left ventricular hypertrophy) and global cardiovascular risk, according to international guidelines, were analyzed. Left ventricular mass index and ejection fraction by echocardiography and E/A ratio, by pulsed-wave Doppler, were calculated. The low education group was characterized by a significantly higher prevalence of patients with visceral obesity (P=.021), hypertension (P=.010), metabolic syndrome (P=.000), and microalbuminuria (P=.000) and greater global cardiovascular risk (P=.000). Significantly increased levels of microalbuminuria (P=.000) and significantly decreased values of E/A ratio (P=.000) were also detected in the low education group. Global cardiovascular risk correlated directly with waist-to-hip ratio (P=.010), microalbuminuria (P=.015), and the metabolic syndrome (P>.012) and inversely with educational status (P=.000). Education was independently (P=.000) associated with global cardiovascular risk. These data indicate a strong association between low education and cardiometabolic comorbidities suitable to influence the evolution of chronic degenerative diseases. Preventive strategies need to be more efficient and more effective in this patient population.

MATERIALI
Numero di prodotto
Marchio
Descrizione del prodotto

Sigma-Aldrich
Colesterolo, Sigma Grade, ≥99%
Sigma-Aldrich
Fosfato di sodio, meets analytical specification of Ph. Eur., BP, E339, 98.5-102.5% (T)
Sigma-Aldrich
Dibutilftalato, 99%
Sigma-Aldrich
Colesterolo, powder, BioReagent, suitable for cell culture, ≥99%
Sigma-Aldrich
Creatinine, anhydrous, ≥98%
Sigma-Aldrich
SyntheChol® NS0 Supplement, 500 ×, synthetic cholesterol, animal component-free, sterile-filtered, aqueous solution, suitable for cell culture
Sigma-Aldrich
Fosfato di sodio, puriss. p.a., crystallized, ≥99.0% (T)
Sigma-Aldrich
Fosfato di sodio, BioXtra, ≥99.0% (T)
Sigma-Aldrich
Colesterolo, from sheep wool, ≥92.5% (GC), powder
Supelco
Colesterolo, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Fosfato di sodio, tested according to Ph. Eur.
Supelco
Cholesterol solution, certified reference material, 10 mg/mL in chloroform
Supelco
Creatinine, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Dibutilftalato, PESTANAL®, analytical standard
Supelco
Dibutilftalato, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
SAFC
Colesterolo, from sheep wool, Controlled origin, meets USP/NF testing specifications
Sigma-Aldrich
Colesterolo, from lanolin, ≥99.0% (GC)
Sigma-Aldrich
Colesterolo, tested according to Ph. Eur.
Dibutilftalato, European Pharmacopoeia (EP) Reference Standard